Results
|
|
1981.
|
|
|
|
1982.
|
|
|
|
1983.
|
|
|
|
1984.
|
|
|
|
1985.
|
|
|
|
1986.
|
1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia. [electronic resource] by
- Anandan, Sampath-Kumar
- Webb, Heather Kay
- Chen, Dawn
- Wang, Yi-Xin Jim
- Aavula, Basker R
- Cases, Sylvaine
- Cheng, Ying
- Do, Zung N
- Mehra, Upasana
- Tran, Vinh
- Vincelette, Jon
- Waszczuk, Joanna
- White, Kathy
- Wong, Kenneth R
- Zhang, Le-Ning
- Jones, Paul D
- Hammock, Bruce D
- Patel, Dinesh V
- Whitcomb, Randall
- MacIntyre, D Euan
- Sabry, James
- Gless, Richard
Producer: 20110502
In:
Bioorganic & medicinal chemistry letters vol. 21
Availability: No items available.
|
|
|
1987.
|
|
|
|
1988.
|
|
|
|
1989.
|
Efficacy and safety of vildagliptin in new-onset diabetes after kidney transplantation--a randomized, double-blind, placebo-controlled trial. [electronic resource] by
- Haidinger, M
- Werzowa, J
- Hecking, M
- Antlanger, M
- Stemer, G
- Pleiner, J
- Kopecky, C
- Kovarik, J J
- Döller, D
- Pacini, G
- Säemann, M D
Producer: 20140812
In:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons vol. 14
Availability: No items available.
|
|
|
1990.
|
|
|
|
1991.
|
|
|
|
1992.
|
|
|
|
1993.
|
|
|
|
1994.
|
|
|
|
1995.
|
|
|
|
1996.
|
|
|
|
1997.
|
|
|
|
1998.
|
|
|
|
1999.
|
|
|
|
2000.
|
|